AU4429100A - The process for manufacturing topical ophthalmic preparations without systemic effects - Google Patents

The process for manufacturing topical ophthalmic preparations without systemic effects

Info

Publication number
AU4429100A
AU4429100A AU44291/00A AU4429100A AU4429100A AU 4429100 A AU4429100 A AU 4429100A AU 44291/00 A AU44291/00 A AU 44291/00A AU 4429100 A AU4429100 A AU 4429100A AU 4429100 A AU4429100 A AU 4429100A
Authority
AU
Australia
Prior art keywords
systemic effects
topical ophthalmic
ophthalmic preparations
manufacturing topical
manufacturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44291/00A
Other languages
English (en)
Inventor
Bakulesh Mafatlal Khamar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU4429100A publication Critical patent/AU4429100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU44291/00A 1999-02-03 2000-02-02 The process for manufacturing topical ophthalmic preparations without systemic effects Abandoned AU4429100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN90/BOM/99 1999-02-03
IN90BO1999 IN185228B (enrdf_load_stackoverflow) 1999-02-03 1999-02-03
PCT/IN2000/000008 WO2000049990A2 (en) 1999-02-03 2000-02-02 The process for manufacturing topical ophthalmic preparations without systemic effects

Publications (1)

Publication Number Publication Date
AU4429100A true AU4429100A (en) 2000-09-14

Family

ID=11077485

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44291/00A Abandoned AU4429100A (en) 1999-02-03 2000-02-02 The process for manufacturing topical ophthalmic preparations without systemic effects

Country Status (11)

Country Link
EP (1) EP1139970A2 (enrdf_load_stackoverflow)
AP (1) AP2000001977A0 (enrdf_load_stackoverflow)
AU (1) AU4429100A (enrdf_load_stackoverflow)
BR (1) BR0004530A (enrdf_load_stackoverflow)
CA (1) CA2326690A1 (enrdf_load_stackoverflow)
EA (1) EA200000918A1 (enrdf_load_stackoverflow)
ID (1) ID28121A (enrdf_load_stackoverflow)
IL (1) IL138824A0 (enrdf_load_stackoverflow)
IN (1) IN185228B (enrdf_load_stackoverflow)
WO (1) WO2000049990A2 (enrdf_load_stackoverflow)
ZA (1) ZA200006252B (enrdf_load_stackoverflow)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001273269B2 (en) * 2000-07-14 2005-08-11 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
AU2005220199B2 (en) * 2000-07-14 2007-03-08 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8858961B2 (en) 2000-07-14 2014-10-14 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
DE10132876A1 (de) * 2001-07-06 2003-01-30 Medproject Pharma Entwicklungs Zweiphasige, tropfbare Hydrogele zur Anwendung am Auge
US7439241B2 (en) 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
NZ552325A (en) 2004-05-25 2010-11-26 Sansrosa Pharmaceutical Dev Inc The use of alpha 2 andrenoceptor agonists such as brimonidine for treating inflammatory skin disorders
EP2329849B1 (en) 2009-11-18 2015-04-29 Galderma Research & Development Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder
FR2977493B1 (fr) 2011-07-05 2014-02-14 Galderma Res & Dev Nouvelle composition anesthesique stable pour la reduction des reactions cutanees
BR112015019546A2 (pt) 2013-02-15 2017-07-18 Allergan Inc implante de distribuição de drogas prolongado
WO2014150899A1 (en) * 2013-03-15 2014-09-25 Chapin Matthew J Topical ophthalmic formulations for treating migraine
WO2016172712A2 (en) 2015-04-23 2016-10-27 Sydnexis, Inc. Ophthalmic composition
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
US11382909B2 (en) 2014-09-05 2022-07-12 Sydnexis, Inc. Ophthalmic composition
JP2018521000A (ja) 2015-05-29 2018-08-02 シドネキシス，インク． Ｄ２ｏで安定化された医薬製剤
GB202110420D0 (en) * 2021-07-20 2021-09-01 Rosemont Pharmaceuticals Ltd Liquid pharmaceutical composition of clonidine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
DD294174A5 (de) * 1990-05-04 1991-09-26 Sigrid Keipert Ophthalmika mit retardwirkung und ein neues verfahren zu ihrer herstellung
FR2678832B1 (fr) * 1991-07-10 1995-03-17 Europhta Sa Laboratoire Nouvelles compositions ophtalmiques a resorption amelioree et leurs procedes de preparation.
FR2679773A1 (fr) * 1991-07-30 1993-02-05 Merck Sharp & Dohme Preparation ophtalmique contenant un agent osmotique acceptable antimicrobien.
DE19614823A1 (de) * 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001273269B2 (en) * 2000-07-14 2005-08-11 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
AU2005220199B2 (en) * 2000-07-14 2007-03-08 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components

Also Published As

Publication number Publication date
IN185228B (enrdf_load_stackoverflow) 2000-12-09
EP1139970A2 (en) 2001-10-10
BR0004530A (pt) 2001-04-03
WO2000049990A3 (en) 2001-07-26
CA2326690A1 (en) 2000-08-31
IL138824A0 (en) 2001-10-31
ID28121A (id) 2001-05-03
EA200000918A1 (ru) 2001-10-22
ZA200006252B (en) 2001-11-29
WO2000049990A2 (en) 2000-08-31
AP2000001977A0 (en) 2000-12-31

Similar Documents

Publication Publication Date Title
AU4211600A (en) Modified lipid production
AU7859800A (en) Topical nasal treatment
AU4429100A (en) The process for manufacturing topical ophthalmic preparations without systemic effects
AU2002245115A1 (en) Monolithic part and process for making the same
AU2001267831A1 (en) DDS compound and process for the preparation thereof
AU4905499A (en) Topical aciclovir formulations
AU5651799A (en) Remedies for photochemotherapy
AU1538901A (en) Polymersation process
AU3285700A (en) Workbench
AU4090299A (en) Liposomal delivery complex
AU7446900A (en) Thioalkylamine derivatives and process for the preparation thereof
AU4396900A (en) Flouring process
AU2001252671A1 (en) Pyridobenzodiazine derivatives and processes for the preparation thereof
AU2001266031A1 (en) Process for drying amoxicillin
AU2943400A (en) Process for the preparation of alpha-aminoketone derivatives
AU1151501A (en) Stud for tire
AU3191100A (en) Ligand-bonded complex
AU4508101A (en) Lipid nanotubules for topical delivery
AU1091901A (en) Shopping advisor component
AU2829700A (en) Processes for the preparation of alpha-aminoketones
AU6870500A (en) Process for the preparation of 2,3-dihydroazepine derivatives
AU3624400A (en) Chromatographic albumin process
AU2001252254A1 (en) 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparationthereof and use thereof
AU3837100A (en) Vitamin d derivatives and process for producing the same
AU4146500A (en) Icecream-type pharmaceutical formulation and process for preparing the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase